Log in or Sign up for Free to view tailored content for your specialty!
Gout News
Genetics play role in how DASH diet impacts gout risk among women
Although the DASH diet can lower gout risk in women regardless of genetics, nonadherence can result in a greater risk in those with a higher predisposition for elevated serum urate, according to a speaker at the EULAR 2021 Congress.
EULAR: Inflammatory arthritis routine care should include self-management strategies
Routine care for inflammatory arthritis should include self-management strategies that feature problem-solving, goal-setting and, if possible, cognitive behavioral therapy, according to new EULAR recommendations.
Log in or Sign up for Free to view tailored content for your specialty!
Methotrexate plus pegloticase improves gout evaluations, patient outcomes at 1 year
Concomitant use of methotrexate and pegloticase resulted in “meaningful” improvements in joint assessments and patient-reported outcomes at 12 months in uncontrolled gout, according to data presented at the EULAR 2021 Virtual Congress.
Widespread unaddressed arthritis pain prompts physicians to 'rethink the conversation'
Findings from the Live Yes! INSIGHTS survey from the Arthritis Foundation showed that out of some 40,000 patient responses, 100% reported experiencing some kind of pain within the last 7 days.
EULAR: Studies on work participation should identify contextual factors upfront
Studies that feature work participation as an outcome in patients with inflammatory arthritis should identify key contextual factors — such as job type or social security system — upfront, according to new “points to consider” from EULAR.
Pegloticase plus mycophenolate mofetil yields 86% response rate in uncontrolled gout
Concomitant use of mycophenolate mofetil with pegloticase demonstrated clinically meaningful improvement in 86% of patients with uncontrolled gout, compared with pegloticase alone, according to data published in Arthritis & Rheumatology.
Pegloticase effectively treated gout in patients on dialysis, may lower ESA use
A study of patients on hemodialysis found pegloticase was successful in treating gout, while also demonstrating the potential to lower erythropoiesis-stimulating agent dose requirements following the therapy.
Rituximab should be 'prescribed with caution' due to possible risk for severe COVID-19
Rituximab was associated with more severe COVID-19 in patients with inflammatory rheumatic and musculoskeletal diseases, according to data published in The Lancet Rheumatology.
Time-related biases in studies distort allopurinol efficacy for reducing mortality in gout
Although multiple observational studies in gout have reported significantly diminished mortality with allopurinol, these cannot be used as evidence due to time-related biases that exaggerate the drug’s benefits, according to data.
Midlife weight gain, persistent obesity raise risk for gout
Weight gain from early adulthood to midlife, as well as consistent obesity throughout adulthood, were associated with an increased risk for gout, according to data published in Arthritis Research & Therapy.
-
Headline News
‘Having women at the top’ drives structural change, advances gender equity in GI
January 13, 202510 min read -
Headline News
Do I really have to go to the hospital for my mini stroke?
January 09, 20257 min read -
Headline News
Survey shows radiation oncology in ‘dark place’ as prior authorization burden worsens
January 14, 20255 min read
-
Headline News
‘Having women at the top’ drives structural change, advances gender equity in GI
January 13, 202510 min read -
Headline News
Do I really have to go to the hospital for my mini stroke?
January 09, 20257 min read -
Headline News
Survey shows radiation oncology in ‘dark place’ as prior authorization burden worsens
January 14, 20255 min read